A detailed history of Grant transactions in Amgen Inc stock. As of the latest transaction made, Grant holds 738 shares of AMGN stock, worth $217,363. This represents 0.12% of its overall portfolio holdings.

Number of Shares
738
Previous 809 8.78%
Holding current value
$217,363
Previous $252,000 5.95%
% of portfolio
0.12%
Previous 0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$309.38 - $337.38 $21,965 - $23,953
-71 Reduced 8.78%
738 $237,000
Q2 2024

Jul 22, 2024

BUY
$262.75 - $319.31 $212,564 - $258,321
809 New
809 $252,000
Q4 2023

Jan 30, 2024

BUY
$255.7 - $288.46 $175,410 - $197,883
686 New
686 $197,000
Q3 2022

Nov 02, 2022

BUY
$224.46 - $253.15 $203,809 - $229,860
908 New
908 $236,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Grant Portfolio

Follow Grant and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grant, based on Form 13F filings with the SEC.

News

Stay updated on Grant with notifications on news.